We use cookies and other tools to enhance your experience on our website and to analyze our web traffic.
For more information about these cookies and the data collected, please refer to our
Privacy Policy.
Posted by
remomueller
on
March 11, 2015
in
Showcase
...
of individuals: the top two plots are for two MZ twin pairs, the lower two plots are for two age/sex-matched pairs of individuals.
...
similar profiles – the two twins in the top-left
...
Posted by
michaelprerau
on
November 29, 2021
in
Guest Blogger
...
waves are associated with two distinct subtypes of spindles.
...
our results illustrate that two distinct subtypes of slow
...
supports a model of two different slow wave and
...
...
sof data and the two sets of annotations, the
...
profusion file. Besides the two lists having different lengths
...
When I checked the two sets against the actually
...
...
Research Lab consists of two sleep rooms and a
...
In addition to the two recording systems, the control
...
review and analysis. The two sleep rooms and control
...
abi_overall
under
Clinical Data/Vital Signs/Seated Blood Pressure
in
HCHS variables
Ankle Brachial Index (ABI) is the average ankle to arm systolic pressures as measured from the left and right sides. The higher of the two ankle measures on the same side is divided by the higher of the two systolic arm pressures to derive the right and left side ABI values. The overall ABI is the mean of those two measurements.
nsrr_bp_diastolic
under
Harmonized/Clinical Data
in
WSC variables
Average resting diastolic blood pressure of two measurements collected from the upper arm in a single clinic visit.When more than two measurements were collected, the average was calculated using the two closest measurements.Harmonized by the NSRR team to align with TOPMed and BioDataCatalyst standards. Source: :dbp_mean:
nsrr_bp_systolic
under
Harmonized/Clinical Data
in
WSC variables
Average resting systolic blood pressure of two measurements collected from the upper arm in a single clinic visit. When more than two measurements were collected, the average was calculated using the two closest measurements.Harmonized by the NSRR team to align with TOPMed and BioDataCatalyst standards. Source: :sbp_mean:
a2a2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking ANGIOTENSIN TYPE 2 ANTAGONISTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
a2ad2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
ace2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking angiotensin-converting-enzyme inhibitor (ACE) INHIBITORS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
aced2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking angiotensin-converting-enzyme inhibitor (ACE) INHIBITORS WITH DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
adpi2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking INHIBITORS OF Adenosine Diphosphate (ADP)-INDUCED PLATELET AGGREGATION within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
agdi2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking ALPHA-GLUCOSIDASE INHIBITORS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
alpha2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking ALPHA-BLOCKERS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
alphad2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking ALPHA-BLOCKERS WITH DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
alzh2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZHEIMERS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
amlod2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking AMLODIPINE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
anar1a2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking ANTI-ARRHYTHMICS, CLASS 1A within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
anar1b2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking ANTI-ARRHYTHMICS, CLASS 1B within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
anar1c2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking ANTI-ARRHYTHMICS, CLASS 1C within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
anar32
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking ANTI-ARRHYTHMICS, CLASS 3 within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
asa2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS) within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
basq2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking BILE-ACID SEQUESTRANTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
benzod2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking BENZODIAZEPINES within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
beta2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking BETA-BLOCKERS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.